136 related articles for article (PubMed ID: 8011538)
41. Translocation t(7;11)(P15;P15) in a patient with therapy-related acute myeloid leukemia following bimolane and ICRF-154 treatment for psoriasis.
Xue Y; Guo Y; Xie X
Leuk Res; 1997 Feb; 21(2):107-9. PubMed ID: 9112426
[TBL] [Abstract][Full Text] [Related]
42. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
[TBL] [Abstract][Full Text] [Related]
43. Myelodysplastic syndrome with t(9;11)(p22;q23) after treatment for B-cell acute lymphoblastic leukemia without epipodophyllotoxins.
Kubota M; Hoshino Y; Doi H; Ueno H; Nishida Y; Hirota H; Akiyama Y
Acta Haematol; 1994; 92(1):33-5. PubMed ID: 7985479
[TBL] [Abstract][Full Text] [Related]
44. [Secondary leukemia after etoposide treatment involved MLL gene rearrangement].
Iida H; Taji H; Iida M; Suzuki R; Sugihara T; Minami S; Kodera Y; Yamamoto K; Seto M; Ueda R
Rinsho Ketsueki; 1994 Jun; 35(6):569-75. PubMed ID: 8078192
[TBL] [Abstract][Full Text] [Related]
45. Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB.
Griesinger F; Metz M; Trümper L; Schulz T; Haase D
Lung Cancer; 2004 May; 44(2):261-5. PubMed ID: 15084391
[TBL] [Abstract][Full Text] [Related]
46. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
47. MLL gene rearrangement in acute myelogenous leukemia after exposure to tegafur/uracil.
Fukushima T; Yoshio N; Noto Y; Kida H
Int J Hematol; 2002 Feb; 75(2):178-81. PubMed ID: 11939265
[TBL] [Abstract][Full Text] [Related]
48. Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).
Sakugawa M; Kojima K; Kaneda K; Masuda K; Dansako H; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M; Tanimoto M
Ann Hematol; 2001 Dec; 80(12):763-6. PubMed ID: 11797121
[TBL] [Abstract][Full Text] [Related]
49. After the treated mole.
Rashidi A; Maherus EM
Blood; 2014 May; 123(18):2757. PubMed ID: 24904937
[No Abstract] [Full Text] [Related]
50. Faggot cells in an HIV-positive patient with inv(16)/therapy-related acute myeloid leukaemia.
Jerez A; del Mar Osma M; Amigo M; Ortuño FJ
Br J Haematol; 2010 Sep; 150(6):646. PubMed ID: 20666775
[No Abstract] [Full Text] [Related]
51. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
[No Abstract] [Full Text] [Related]
52. Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide?
Goto H; Shimazaki C; Tatsumi T; Yamagata N; Inaba T; Fujita N; Moriguchi T; Yamamoto K; Seto M; Ueda R
Int J Hematol; 1994 Aug; 60(2):145-9. PubMed ID: 7948964
[TBL] [Abstract][Full Text] [Related]
53. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
54. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
[TBL] [Abstract][Full Text] [Related]
55. Variant translocations (9;11): identification of the critical genetic rearrangement.
Harris BN; Davis EM; Le Beau MM; Bitter MA; Kaminer LS; Morgan E; Rowley JD
Cancer Genet Cytogenet; 1988 Jan; 30(1):171-5. PubMed ID: 3422044
[TBL] [Abstract][Full Text] [Related]
56. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
Snijder S; Mellink CH; van der Lelie H
Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
[TBL] [Abstract][Full Text] [Related]
57. Therapy-related, mixed phenotype acute leukemia with t(1;21)(p36;q22) and RUNX1 rearrangement.
Yamamoto K; Sada A; Kawano Y; Katayama Y; Shimoyama M; Matsui T
Cancer Genet Cytogenet; 2010 Sep; 201(2):122-7. PubMed ID: 20682397
[TBL] [Abstract][Full Text] [Related]
58. Acute promyelocytic leukaemia with t(11;17)(q23;q12-21) and a good initial response to prolonged ATRA and combination chemotherapy.
Culligan DJ; Stevenson D; Chee YL; Grimwade D
Br J Haematol; 1998 Feb; 100(2):328-30. PubMed ID: 9488621
[TBL] [Abstract][Full Text] [Related]
59. Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome.
Rowley JD; Diaz MO; Espinosa R; Patel YD; van Melle E; Ziemin S; Taillon-Miller P; Lichter P; Evans GA; Kersey JH
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9358-62. PubMed ID: 2251277
[TBL] [Abstract][Full Text] [Related]
60. A novel chromosomal rearrangement associated with therapy-related acute leukemia.
Powell J; Traweek T; Beatty O; Qumsiyeh MB; Rosoff PM
Cancer Genet Cytogenet; 1999 Jul; 112(2):173-7. PubMed ID: 10686948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
